• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.

作者信息

Eron Joseph J, Bosch Ronald J, Bettendorf Daniel, Petch Leslie, Fiscus Susan, Frank Ian

出版信息

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):249-51. doi: 10.1097/QAI.0b013e318050d61f.

DOI:10.1097/QAI.0b013e318050d61f
PMID:17527095
Abstract
摘要

相似文献

1
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.拉米夫定治疗及M184V对去羟肌苷抗逆转录病毒活性的影响。
J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):249-51. doi: 10.1097/QAI.0b013e318050d61f.
2
Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients.M184V突变对核苷类逆转录酶抑制剂经治患者换用去羟肌苷或维持拉米夫定治疗的临床影响。
J Infect Dis. 2003 Aug 15;188(4):537-40. doi: 10.1086/377742. Epub 2003 Jul 24.
3
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.对于初治的HIV感染患者，司他夫定、拉米夫定和奈韦拉平每日一次联合治疗的疗效和安全性
Antivir Ther. 2005;10(5):605-14.
4
The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.HIV-1逆转录酶中M184V突变对含或不含去羟肌苷的高效抗逆转录病毒治疗方案病毒学结果的影响。
Antivir Ther. 2005;10(2):357-61.
5
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.在一名感染HIV-1且对包括替诺福韦酯在内的抗逆转录病毒治疗方案治疗失败的患者中选择一种罕见的耐药谱。
J Clin Virol. 2005 Mar;32(3):241-4. doi: 10.1016/j.jcv.2004.05.020.
6
Focusing on the second phase of plasma HIV-1 RNA clearance.
AIDS. 1997 Feb;11(2):264-6.
7
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection.
AIDS. 2001 Jan 26;15(2):275-7. doi: 10.1097/00002030-200101260-00020.
8
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.对接受司他夫定与去羟肌苷或齐多夫定与拉米夫定治疗的患者的1型人类免疫缺陷病毒分离株的基因型和表型耐药模式进行比较。
J Infect Dis. 2001 Sep 15;184(6):781-4. doi: 10.1086/323088. Epub 2001 Aug 7.
9
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.ALBI试验结果：对初治抗逆转录病毒治疗患者中司他夫定/去羟肌苷、齐多夫定/拉米夫定及交替治疗的随机对照比较
Antivir Ther. 1999;4 Suppl 3:71-4.
10
Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.抗逆转录病毒联合疗法（齐多夫定/去羟肌苷或齐多夫定/拉米夫定）对感染人类免疫缺陷病毒的儿童和青少年血浆中人类免疫缺陷病毒核糖核酸定量的影响。
J Pediatr. 1997 Feb;130(2):293-9. doi: 10.1016/s0022-3476(97)70358-5.

引用本文的文献

1
Understanding drug resistance patterns across different classes of antiretrovirals used in HIV-1-infected treatment-Naïve and experienced patients in Mumbai, India.了解印度孟买初治和经治的HIV-1感染患者中使用的不同类别抗逆转录病毒药物的耐药模式。
Indian J Sex Transm Dis AIDS. 2022 Jul-Dec;43(2):150-155. doi: 10.4103/ijstd.ijstd_101_20. Epub 2022 Nov 17.
2
Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG.波多黎各HIV-1病毒的分子流行病学：HIV-1 C亚型、D亚型和CRF-24BG的新病例
AIDS Res Hum Retroviruses. 2018 Jun;34(6):507-516. doi: 10.1089/AID.2017.0305. Epub 2018 May 23.
3
HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.
中国山东省接受抗逆转录病毒治疗的HIV阳性个体中的HIV耐药性
PLoS One. 2017 Jul 27;12(7):e0181997. doi: 10.1371/journal.pone.0181997. eCollection 2017.
4
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Cavidi ExaVir 病毒载量检测法和超敏 P24 检测法与罗氏 Monitor HIV-1 RNA 检测法的性能特征比较。
J Clin Virol. 2010 Nov;49(3):198-204. doi: 10.1016/j.jcv.2010.07.022. Epub 2010 Sep 15.
5
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.HIV-1耐药性突变：高效抗逆转录病毒治疗第二个十年的更新框架
AIDS Rev. 2008 Apr-Jun;10(2):67-84.